Trial Profile
The Role of Hemolysis in Promoting Thrombosis During Mechanical Circulatory Support With Continuous Flow Pumps (Aim 2)
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 14 Feb 2024
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms Aim 2; SToPClot
- 08 Feb 2024 Status changed from recruiting to completed.
- 03 Nov 2022 Planned End Date changed from 30 Aug 2023 to 30 Dec 2023.
- 03 Nov 2022 Planned primary completion date changed from 30 Aug 2023 to 30 Dec 2023.